Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation NCT04626726 Adult B Acute L...
CD19 CAR-T
CD22 CAR-T
CD19+CD22 CAR-T
Fludarabine
Cyclophosphamid...
14 Years - 65 Years Hebei Senlang Biotechnology Inc., Ltd. View Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia NCT02997761 Adult B Acute L...
Philadelphia Ch...
Blinatumomab
Ibrutinib
18 Years - University of California, Davis View Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia NCT00075725 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Veliparib and Temozolomide in Treating Patients With Acute Leukemia NCT01139970 Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult B Acute L...
Adult B Acute L...
Adult T Acute L...
Alkylating Agen...
Chronic Myelomo...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
18 Years - National Cancer Institute (NCI) View Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) NCT00866307 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Prophylactic Cr...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia NCT00075725 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia NCT00792948 Acute Lymphobla...
Adult B Acute L...
Adult B Acute L...
Adult L1 Acute ...
Adult L2 Acute ...
Adult T Acute L...
Recurrent Adult...
Allogeneic Hema...
Cyclophosphamid...
Cytarabine
Dasatinib
Dexamethasone
Doxorubicin Hyd...
Etoposide
Filgrastim
Laboratory Biom...
Leucovorin Calc...
Methotrexate
Methylprednisol...
Peripheral Bloo...
Prednisone
Sirolimus
Tacrolimus
Total-Body Irra...
Vincristine Sul...
18 Years - 60 Years National Cancer Institute (NCI) View Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia NCT02997761 Adult B Acute L...
Philadelphia Ch...
Blinatumomab
Ibrutinib
18 Years - University of California, Davis View Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation NCT04626726 Adult B Acute L...
CD19 CAR-T
CD22 CAR-T
CD19+CD22 CAR-T
Fludarabine
Cyclophosphamid...
14 Years - 65 Years Hebei Senlang Biotechnology Inc., Ltd. View Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia NCT00075725 Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Veliparib and Temozolomide in Treating Patients With Acute Leukemia NCT01139970 Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult B Acute L...
Adult B Acute L...
Adult T Acute L...
Alkylating Agen...
Chronic Myelomo...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
18 Years - National Cancer Institute (NCI) View Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia NCT02129062 Adult B Acute L...
Adult B Acute L...
Recurrent Adult...
Ibrutinib
Laboratory Biom...
18 Years - National Cancer Institute (NCI) View Veliparib and Temozolomide in Treating Patients With Acute Leukemia NCT01139970 Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult B Acute L...
Adult B Acute L...
Adult T Acute L...
Alkylating Agen...
Chronic Myelomo...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
18 Years - National Cancer Institute (NCI) View Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection NCT02109224 Adult B Acute L...
Chronic Lymphoc...
Cutaneous B-Cel...
Extranodal Marg...
HIV Infection
Intraocular Lym...
Multicentric An...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Chro...
Refractory Hair...
Refractory Plas...
Small Intestina...
Splenic Margina...
Testicular Lymp...
Waldenstrom Mac...
Ibrutinib
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI) View